This is particularly relevant in light of the remarkable role of the LIV-1 family of zinc transporters in breast cancer and the regulation of free zinc signaling by casein kinase 2, which have been extensively investigated by the group of Kathryn Taylor [33]. This evidence concerns the gene SLC39A6 and breast cancer.